MktsMarkets

Achieve Life Sciences, Inc.
NASDAQ: ACHVKey statistics
ACHV News
Stories mentioning ACHV from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | (19,124) | 5,320 | 6,707 | 7,097 | 7,296 | 7,609 | 5,113 | |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | ||||||||
| Interest Income | 297.00 | 427.00 | 554.00 | 192.00 | 322.00 | 482.00 | 673.00 | 833.00 |
| Interest Expense | 366.00 | 804.00 | ||||||
| Other Expense | (13.00) | 7.00 | (5.00) | (59.00) | 21.00 | (5.00) | (8.00) | (2.00) |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (10,168) | (14,662) | (14,441) | (12,718) | (12,827) | (12,360) | (12,512) | (8,461) |
| Earnings Per Share (Basic) | (0.19) | (0.34) | (0.28) | (0.37) | (0.37) | (0.39) | (0.36) | (0.25) |
| Earnings Per Share (Diluted) | (0.19) | (0.34) | (0.28) | (0.37) | (0.37) | (0.39) | (0.36) | (0.25) |
| Weighted Average Shares Outstanding (Basic) | 53,382 | 43,595 | 51,018 | 34,685 | 34,685 | 32,071 | 34,355 | 34,319 |
| Weighted Average Shares Outstanding (Diluted) | 53,382 | 43,595 | 51,018 | 34,685 | 34,685 | 32,071 | 34,355 | 34,319 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ACHV
Achieve Life Sciences, Inc. (NASDAQ: ACHV) is a stock listed on the Nasdaq Stock Market under the ticker symbol ACHV. It last traded at $6.49 (Oct 23, 2026, 4:00 PM ET), down 0.1% on the day. That gives Achieve Life Sciences a market capitalisation of $667.8M.
Over the past 52 weeks ACHV has traded between $2.62 and $8.64.
For the quarter ended Mar 31, 2026 it reported a net loss of $10.2M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$10.2M |
| Dec 31, 2025 | — | -$14.7M |
| Sep 30, 2025 | — | -$14.4M |
| Jun 30, 2025 | — | -$12.7M |
From Achieve Life Sciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…